NCBI Taxonomy: 698722

Cystophora monilifera (ncbi_taxid: 698722)

found 30 associated metabolites at species taxonomy rank level.

Ancestor: Cystophora

Child Taxonomies: none taxonomy data.

gamma-Tocotrienol

(2R)-3,4-Dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrien-1-yl]-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


gamma-Tocotrienol, also known as 7,8-dimethyltocotrienol, belongs to the class of organic compounds known as tocotrienols. These are vitamin E derivatives containing an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain attached to the C6 atom of a benzopyran ring system. They differ from tocopherols that contain a saturated trimethyltridecyl chain. Thus, gamma-tocotrienol is considered to be a quinone lipid molecule. gamma-Tocotrienol is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. gamma-Tocotrienol targets cancer cells by inhibiting Id1, a key cancer-promoting protein. gamma-Tocotrienol was shown to trigger cell apoptosis and well as anti-proliferation of cancer cells. This mechanism was also observed in separate prostate cancer and melanoma cell line studies. Constituent of palm oil. Nutriceutical with anticancer props. and a positive influence on the blood lipid profile. gamma-Tocotrienol is found in many foods, some of which are rye, corn, rosemary, and common grape. Acquisition and generation of the data is financially supported in part by CREST/JST. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3]. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3].

   

delta-Tocotrienol

(2R)-2,8-Dimethyl-2-[(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]-3,4-dihydro-2H-1-benzopyran-6-ol

C27H40O2 (396.3028)


delta-Tocotrienol, also known as 8-methyltocotrienol, belongs to the class of organic compounds known as tocotrienols. These are vitamin E derivatives containing an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain attached to the carbon C6 atom of a benzopyran ring system. They differ from tocopherols that contain a saturated trimethyltridecyl chain. Thus, delta-tocotrienol is considered to be a quinone lipid molecule. delta-Tocotrienol is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. delta-Tocotrienol is found in American cranberry and palm oil. It is a nutriceutical with anticancer properties and a positive influence on the blood lipid profile. Constituent of palm oil. Nutriceutical with anticancer props. and a positive influence on the blood lipid profile. d-Tocotrienol is found in many foods, some of which are fennel, caraway, coconut, and lichee. Acquisition and generation of the data is financially supported in part by CREST/JST.

   

(2R)-2,8-Dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol

2,8-dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-2H-1-benzopyran-6-ol

C27H40O2 (396.3028)


   

(2R)-2,7,8-Trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol

2,7,8-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


   

gamma-Tocotrienol

2,7,8-TRIMETHYL-2-[(3E,7E,11E,15E,19E,23E,27E)-4,8,12,16,20,24,28,32-O CTAMETHYL-3,7,11,15,19,23,27,31-TRITRIACONTAOCTAENYL]-6-CHROMANOL

C28H42O2 (410.3185)


gamma-Tocotrienol, also known as 7,8-dimethyltocotrienol, belongs to the class of organic compounds known as tocotrienols. These are vitamin E derivatives containing an unsaturated trimethyltrideca-3,7,11-trien-1-yl chain attached to the C6 atom of a benzopyran ring system. They differ from tocopherols that contain a saturated trimethyltridecyl chain. Thus, gamma-tocotrienol is considered to be a quinone lipid molecule. gamma-Tocotrienol is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. gamma-Tocotrienol targets cancer cells by inhibiting Id1, a key cancer-promoting protein. gamma-Tocotrienol was shown to trigger cell apoptosis and well as anti-proliferation of cancer cells. This mechanism was also observed in separate prostate cancer and melanoma cell line studies. Gamma-tocotrienol is a tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 7 and 8 and a farnesyl chain at position 2. A vitamin E family member that has potent anti-cancer properties against a wide-range of cancers. It has a role as an antioxidant, an antineoplastic agent, a plant metabolite, a radiation protective agent, an apoptosis inducer and a hepatoprotective agent. It is a tocotrienol and a vitamin E. gamma-Tocotrienol is a natural product found in Amaranthus cruentus, Triadica sebifera, and other organisms with data available. A tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2, 7 and 8 and a farnesyl chain at position 2. A vitamin E family member that has potent anti-cancer properties against a wide-range of cancers. Constituent of palm oil. Nutriceutical with anticancer props. and a positive influence on the blood lipid profile. gamma-Tocotrienol is found in many foods, some of which are rye, corn, rosemary, and common grape. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3]. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3].

   

γ-Tocotrienol

gamma-Tocotrienol

C28H42O2 (410.3185)


γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3]. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3].

   

δ-Tocotrienol

NCGC00253541-03_C27H40O2_(2R)-2,8-Dimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrien-1-yl]-6-chromanol

C27H40O2 (396.3028)


A tocotrienol that is chroman-6-ol substituted by methyl groups at positions 2 and 8 and a farnesyl chain at position 2.

   

Jambone A

Moniliferanone C

C24H34O4 (386.2457)


   

CHEBI:33277

2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethyl-2-[(3E,7E)-4,8,12-trimethyl-3,7,11-tridecatrienyl]-, (2R)- (9CI)

C28H42O2 (410.3185)


γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3]. γ-Tocotrienol is an active form of vitamin E. γ-tocotrienol reverses the multidrug resistance (MDR) of breast cancer cells through the signaling pathway of NF-κB and P-gp. γ-Tocotrienol is also a novel radioprotector agent, can mitigate bone marrow radiation damage during targeted radionuclide treatment[1][2][3].

   

(2R)-2,7,8-Trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trienyl)-3,4-dihydrochromen-6-ol

2,7,8-trimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-3,4-dihydro-2H-1-benzopyran-6-ol

C28H42O2 (410.3185)


   

1-(2,6-dihydroxy-4-methoxyphenyl)octadeca-6,9,12,15-tetraen-1-one

1-(2,6-dihydroxy-4-methoxyphenyl)octadeca-6,9,12,15-tetraen-1-one

C25H34O4 (398.2457)


   

(6z,9z,12z,15z)-1-(2,6-dihydroxy-4-methoxyphenyl)octadeca-6,9,12,15-tetraen-1-one

(6z,9z,12z,15z)-1-(2,6-dihydroxy-4-methoxyphenyl)octadeca-6,9,12,15-tetraen-1-one

C25H34O4 (398.2457)


   

(6z,9z,12z)-1-(2,4,6-trihydroxyphenyl)octadeca-6,9,12-trien-1-one

(6z,9z,12z)-1-(2,4,6-trihydroxyphenyl)octadeca-6,9,12-trien-1-one

C24H34O4 (386.2457)


   

(10e)-9-hydroxy-1-(2,4,6-trihydroxyphenyl)octadeca-6,10,12,15-tetraen-1-one

(10e)-9-hydroxy-1-(2,4,6-trihydroxyphenyl)octadeca-6,10,12,15-tetraen-1-one

C24H32O5 (400.225)


   

1-(2,4,6-trihydroxyphenyl)octadeca-9,12,15-trien-1-one

1-(2,4,6-trihydroxyphenyl)octadeca-9,12,15-trien-1-one

C24H34O4 (386.2457)


   

1-(2,4,6-trihydroxyphenyl)octadeca-6,9,12,15-tetraen-1-one

1-(2,4,6-trihydroxyphenyl)octadeca-6,9,12,15-tetraen-1-one

C24H32O4 (384.23)


   

1-(2,4,6-trihydroxyphenyl)hexadeca-6,9-dien-1-one

1-(2,4,6-trihydroxyphenyl)hexadeca-6,9-dien-1-one

C22H32O4 (360.23)


   

(6z,9z)-1-(2,4,6-trihydroxyphenyl)hexadeca-6,9-dien-1-one

(6z,9z)-1-(2,4,6-trihydroxyphenyl)hexadeca-6,9-dien-1-one

C22H32O4 (360.23)


   

(9z,12z,15z)-1-(2,4,6-trihydroxyphenyl)octadeca-9,12,15-trien-1-one

(9z,12z,15z)-1-(2,4,6-trihydroxyphenyl)octadeca-9,12,15-trien-1-one

C24H34O4 (386.2457)


   

1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,14,17-pentaen-1-one

1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,14,17-pentaen-1-one

C26H34O4 (410.2457)


   

(6z,10e,12z,15z)-9-hydroxy-1-(2,4,6-trihydroxyphenyl)octadeca-6,10,12,15-tetraen-1-one

(6z,10e,12z,15z)-9-hydroxy-1-(2,4,6-trihydroxyphenyl)octadeca-6,10,12,15-tetraen-1-one

C24H32O5 (400.225)


   

9-hydroxy-1-(2,4,6-trihydroxyphenyl)octadeca-6,10,12,15-tetraen-1-one

9-hydroxy-1-(2,4,6-trihydroxyphenyl)octadeca-6,10,12,15-tetraen-1-one

C24H32O5 (400.225)


   

(5z,8z,11z,14z)-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,14-tetraen-1-one

(5z,8z,11z,14z)-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,14-tetraen-1-one

C26H36O4 (412.2613)


   

15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one

15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one

C26H34O5 (426.2406)


   

(5z,8z,11z,14z,17z)-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,14,17-pentaen-1-one

(5z,8z,11z,14z,17z)-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,14,17-pentaen-1-one

C26H34O4 (410.2457)


   

(6z,9z,12z,15z)-1-(2,4,6-trihydroxyphenyl)octadeca-6,9,12,15-tetraen-1-one

(6z,9z,12z,15z)-1-(2,4,6-trihydroxyphenyl)octadeca-6,9,12,15-tetraen-1-one

C24H32O4 (384.23)


   

1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,14-tetraen-1-one

1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,14-tetraen-1-one

C26H36O4 (412.2613)


   

(6z,9r,10e,12z,15z)-9-hydroxy-1-(2,4,6-trihydroxyphenyl)octadeca-6,10,12,15-tetraen-1-one

(6z,9r,10e,12z,15z)-9-hydroxy-1-(2,4,6-trihydroxyphenyl)octadeca-6,10,12,15-tetraen-1-one

C24H32O5 (400.225)


   

1-(2,4,6-trihydroxyphenyl)octadeca-6,9,12-trien-1-one

1-(2,4,6-trihydroxyphenyl)octadeca-6,9,12-trien-1-one

C24H34O4 (386.2457)


   

(5z,8z,11z,13e,17z)-15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one

(5z,8z,11z,13e,17z)-15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one

C26H34O5 (426.2406)